FATE THERAPEUTICS INC
FATECIK 0001434316 · Every Form 4 filed by insiders at this issuer.
Filings
12
Latest Mar 25, 2024
Unique insiders
6
Showing
12 of 12
Page 1
Top insiders
Most active reporters at FATE THERAPEUTICS INC
| Name | Roles | Filings |
|---|---|---|
| Dulac Edward J III | Officer | 5 |
| TAHL CINDY | Officer | 2 |
| Valamehr Bahram | Officer | 2 |
| Wolchko J Scott | OfficerDirector | 2 |
| Green Jeremy | Director10% Owner | 1 |
| Redmile Group, LLC | Director10% Owner | 1 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 25, 2024 | Redmile Group, LLC Director · 10% Owner | Holdings only | — | — | — | |
| Mar 5, 2024 | Dulac Edward J III Chief Financial Officer | S | 2,447 | $7.77 | $19,013 | |
| Feb 2, 2024 | Valamehr Bahram Chief R&D Officer | Holdings only | — | — | — | |
| Feb 2, 2024 | Dulac Edward J III Chief Financial Officer | Holdings only | — | — | — | |
| Feb 2, 2024 | TAHL CINDY General Counsel and Secretary | Holdings only | — | — | — | |
| Feb 2, 2024 | Wolchko J Scott President and CEO · Director | Holdings only | — | — | — | |
| Jan 30, 2024 | Dulac Edward J III Chief Financial Officer | S | 1,849 | $5.00 | $9,245 | |
| Jan 10, 2024 | Dulac Edward J III Chief Financial Officer | S | 7,028 | $4.37 | $30,712 | |
| Jan 10, 2024 | Wolchko J Scott President and CEO · Director | S | 14,391 | $4.37 | $62,889 | |
| Jan 10, 2024 | Valamehr Bahram Chief R&D Officer | S | 11,271 | $4.38 | $49,367 | |
| Jan 10, 2024 | TAHL CINDY General Counsel and Secretary | S | 10,874 | $4.37 | $47,519 | |
| Jan 3, 2024 | Dulac Edward J III Chief Financial Officer | S | 5,182 | $3.66 | $18,966 |
Showing 1–12 of 12
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.